| Yalelaan 60 | VIA EDGAR | |
| 3584 CM Utrecht | ||
| The Netherlands |
March 22, 2021
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attn: | Ms. Christie Wong |
Mr. Al Pavot |
Mr. Chris Edwards |
Mr. Tim Buchmiller |
| Re: | LAVA Therapeutics B.V. |
Registration Statement on Form F-1 |
File No. 333-253795 |
Acceleration Request |
Requested Date: March 24, 2021 |
Requested Time: 4:00 P.M. Eastern Time |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form F-1 to become effective on March 24, 2021, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable, or at such later time as its counsel may orally request via telephone call to the staff. The Registrant hereby authorizes each of Divakar Gupta, Christian Plaza and Josh Kaufman of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Divakar Gupta of Cooley LLP at +1 212 479 6474, Christian Plaza at + 1 703 456 8006 or Josh Kaufman at +1 212 479 6495. Thank you for your assistance with this matter.
[Signature Page Follows]
| Sincerely, | ||
| LAVA THERAPEUTICS B.V. | ||
| By: | /s/ Stephen Hurly | |
| Name: Stephen Hurly. | ||
| Title: Chief Executive Officer | ||
| cc: | Edward Smith, Chief Financial Officer, LAVA Therapeutics B.V. |
Divakar Gupta, Cooley LLP |
Christian Plaza, Cooley LLP |
Josh Kaufman, Cooley LLP |
